rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
23
|
pubmed:dateCreated |
2007-11-6
|
pubmed:abstractText |
3-O-3'(or 2')-Methylsuccinyl-betulinic acid (MSB) derivatives were separated by using recycle HPLC. The structures of four isomers were assigned by NMR and asymmetric synthesis. 3-O-3'S-Methylsuccinyl-betulinic acid (3'S-MSB, 4) exhibited potent anti-HIV activity with an EC(50) value of 0.0087microM and a TI value of 6.3x10(3), which is comparable to the data for bevirimat (DSB, PA-457), a current clinical trials drug that was also derived from betulinic acid. The anti-HIV potency of 4 was slightly better than that of AZT.
|
pubmed:grant |
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/17935987-12076748,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17935987-14573704,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17935987-15225375,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17935987-15353975,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17935987-16942019,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17935987-1919029,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17935987-8176401,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17935987-8676334,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17935987-8909827,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17935987-9459011,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17935987-9469816,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17935987-9873802
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1464-3405
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:day |
1
|
pubmed:volume |
17
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
6553-7
|
pubmed:dateRevised |
2011-4-22
|
pubmed:meshHeading |
pubmed-meshheading:17935987-Acquired Immunodeficiency Syndrome,
pubmed-meshheading:17935987-Anti-HIV Agents,
pubmed-meshheading:17935987-Cell Line, Tumor,
pubmed-meshheading:17935987-HIV-1,
pubmed-meshheading:17935987-Humans,
pubmed-meshheading:17935987-Stereoisomerism,
pubmed-meshheading:17935987-Structure-Activity Relationship,
pubmed-meshheading:17935987-Succinates,
pubmed-meshheading:17935987-Triterpenes,
pubmed-meshheading:17935987-Virus Replication
|
pubmed:year |
2007
|
pubmed:articleTitle |
Anti-AIDS agents 73: structure-activity relationship study and asymmetric synthesis of 3-O-monomethylsuccinyl-betulinic acid derivatives.
|
pubmed:affiliation |
Natural Products Research Laboratories, School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, USA.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, N.I.H., Extramural
|